| abstract |
An anti-angiogenic compound, represented by Chemical Formula I, or a pharmaceutically acceptable salt thereof, a method of preparation thereof, and a pharmaceutically acceptable composition including the same is described. Because the compound of the Chemical Formula I potentially suppresses angiogenesis, the compound of the Chemical Formula I is applicable to the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, and available as an anti- agent angiogenic |